ASCO 2026: Genomics Reveal HRD–Treatment Response Link

• June 5, 2026

Neoadjuvant FinHer regimen in patients with HER2-positive breast cancer: a retrospective audit

• by Anoop T. M., Rona Joseph, Sherin Mathew, Mintu Mathew, Saikumar Soman, Kalai Bharathi, Senthamizhan S

• May 18, 2026

ASCO 2026: FDA-Cleared AI Put to the Test

Multimodal AI platform goes head-to-head with a standard breast cancer assay using routine pathology image

• June 3, 2026

• 3 min

Benchmarking Large Language Models and Prompt Engineering Strategies in Microsatellite Instability Cancers: Evaluation Study

• by Yuxin Zhang, Jie Song, Cheng Bi, Xin Zheng, Zhichuan Xu, Dan Cao, Bairong Shen

• May 21, 2026